The role of BRCA and PARP in DNA repair and BRCA-related breast cancer | Prof. Dr. med. Peter Fasching at St. Gallen Breast Cancer Conference 2015

The role of BRCA and PARP in DNA repair and BRCA-related breast cancer | Prof. Dr. med. Peter Fasching at St. Gallen Breast Cancer Conference 2015

User Photo
EMJ

5 years
685 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany) describes targeting the defect in DNA repair in BRCA-related breast cancer with poly (ADP-ribose) polymerase (PARP) inhibitors.

In BRCA-related breast cancer cells, DNA double-strand break repair is impaired, so inhibition of PARP, which has a role in DNA single-strand break repair, increases the susceptibility for additional DNA damage and cell death. Accordingly, PARP inhibitors may be important novel therapeutic agents for the treatment of BRCA-related breast cancer.

This programme is supported by BioMarin Pharmaceutical



European Medical Journal

Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Up Next Autoplay
>